Bear of the Day: Quest Diagnostics (DGX)

Quest Diagnostics (DGX) second-quarter EPS of $0.89 beat the Zacks Consensus Estimate by a penny and the year-ago quarter by 7 cents. However, revenues declined 1.4% to $1.9 billion, driven by a decline in both volume and pricing. Meanwhile, the company proactively negotiated contracts with some MCOs at reduced prices. Although this gives more visibility, revenue [...]